FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2460811036> ?p ?o ?g. }

• W2460811036 endingPage "3151" @default.
• W2460811036 startingPage "3145" @default.
• W2460811036 abstract "The number of elderly patients with diffuse large B-cell lymphoma (DLBCL) in our aging society continues to rise, although the optimal management of very elderly patients with DLBCL is unknown.This study evaluated 207 patients who were 80 years old or older at the diagnosis of DLBCL from 2002 to 2014 at The University of Texas MD Anderson Cancer Center. Analyzed features included clinical characteristics, treatment outcomes, and tolerability of therapy. Cox proportional hazards models examined relations between the treatment regimen and survival.The median age was 83 years (range, 80-96 years). Fifty-four percent of the patients had intermediate- to high-risk or high-risk International Prognostic Index scores. Fifteen percent had scores of 4 or higher on the Charlson Comorbidity Index (CCI). The initial therapies included rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP; 70%); rituximab, etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (R-EPOCH; 6%); and non-anthracycline-based therapies, including rituximab, cyclophosphamide, etoposide, vincristine, and prednisone (R-CEOP) and rituximab, cyclophosphamide, vincristine, and prednisone (R-CVP; 10%). With a median follow-up of 38.1 months, the 3-year failure-free survival (FFS) and overall survival (OS) rates were 55% and 54%, respectively. Eighty-eight patients experienced relapse during the follow-up, but only 3 patients (3.4%) experienced relapse beyond 3 years. Patients who received R-CHOP or R-EPOCH had significantly longer FFS than those who received R-CEOP or R-CVP, with 3-year FFS rates of 63% for R-CHOP, 74% for R-EPOCH, and 23% for R-CEOP and R-CVP. Male sex, a monocyte count ≥ 500 × 107 /L, and a CCI score ≥ 4 were significantly associated with inferior OS. Extranodal disease (≥2) and a higher CCI score were associated with a high risk of treatment-related mortality.With anthracycline-based regimens such as R-CHOP and R-EPOCH, very elderly patients with DLBCL had superior outcomes similar to those achieved for younger patients with DLBCL. Cancer 2016;122:3145-51. © 2016 American Cancer Society." @default.
• W2460811036 created "2016-07-22" @default.
• W2460811036 creator A5006742031 @default.
• W2460811036 creator A5008122163 @default.
• W2460811036 creator A5021262821 @default.
• W2460811036 creator A5021496101 @default.
• W2460811036 creator A5028677309 @default.
• W2460811036 creator A5032750886 @default.
• W2460811036 creator A5037784199 @default.
• W2460811036 creator A5037878906 @default.
• W2460811036 creator A5044284041 @default.
• W2460811036 creator A5045101860 @default.
• W2460811036 creator A5045132841 @default.
• W2460811036 creator A5055368165 @default.
• W2460811036 creator A5062622724 @default.
• W2460811036 creator A5064752432 @default.
• W2460811036 creator A5070455368 @default.
• W2460811036 creator A5074654320 @default.
• W2460811036 creator A5085712310 @default.
• W2460811036 creator A5089736242 @default.
• W2460811036 date "2016-06-28" @default.
• W2460811036 modified "2023-10-10" @default.
• W2460811036 title "Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma" @default.
• W2460811036 cites W1895923234 @default.
• W2460811036 cites W1958901607 @default.
• W2460811036 cites W1969582706 @default.
• W2460811036 cites W1981824836 @default.
• W2460811036 cites W1982589145 @default.
• W2460811036 cites W1987972761 @default.
• W2460811036 cites W1996904182 @default.
• W2460811036 cites W2000445173 @default.
• W2460811036 cites W2013575415 @default.
• W2460811036 cites W2015884279 @default.
• W2460811036 cites W2028850684 @default.
• W2460811036 cites W2032685816 @default.
• W2460811036 cites W2047299887 @default.
• W2460811036 cites W2064730985 @default.
• W2460811036 cites W2103737663 @default.
• W2460811036 cites W2110334963 @default.
• W2460811036 cites W2110645520 @default.
• W2460811036 cites W2121656227 @default.
• W2460811036 cites W2126086632 @default.
• W2460811036 cites W2126232974 @default.
• W2460811036 cites W2126631675 @default.
• W2460811036 cites W2131424155 @default.
• W2460811036 cites W2144238619 @default.
• W2460811036 cites W2145304413 @default.
• W2460811036 cites W2145770938 @default.
• W2460811036 cites W2152327309 @default.
• W2460811036 cites W2156661621 @default.
• W2460811036 cites W2158267770 @default.
• W2460811036 cites W4205736005 @default.
• W2460811036 doi "https://doi.org/10.1002/cncr.30173" @default.
• W2460811036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27351173" @default.
• W2460811036 hasPublicationYear "2016" @default.
• W2460811036 type Work @default.
• W2460811036 sameAs 2460811036 @default.
• W2460811036 citedByCount "57" @default.
• W2460811036 countsByYear W24608110362017 @default.
• W2460811036 countsByYear W24608110362018 @default.
• W2460811036 countsByYear W24608110362019 @default.
• W2460811036 countsByYear W24608110362020 @default.
• W2460811036 countsByYear W24608110362021 @default.
• W2460811036 countsByYear W24608110362022 @default.
• W2460811036 countsByYear W24608110362023 @default.
• W2460811036 crossrefType "journal-article" @default.
• W2460811036 hasAuthorship W2460811036A5006742031 @default.
• W2460811036 hasAuthorship W2460811036A5008122163 @default.
• W2460811036 hasAuthorship W2460811036A5021262821 @default.
• W2460811036 hasAuthorship W2460811036A5021496101 @default.
• W2460811036 hasAuthorship W2460811036A5028677309 @default.
• W2460811036 hasAuthorship W2460811036A5032750886 @default.
• W2460811036 hasAuthorship W2460811036A5037784199 @default.
• W2460811036 hasAuthorship W2460811036A5037878906 @default.
• W2460811036 hasAuthorship W2460811036A5044284041 @default.
• W2460811036 hasAuthorship W2460811036A5045101860 @default.
• W2460811036 hasAuthorship W2460811036A5045132841 @default.
• W2460811036 hasAuthorship W2460811036A5055368165 @default.
• W2460811036 hasAuthorship W2460811036A5062622724 @default.
• W2460811036 hasAuthorship W2460811036A5064752432 @default.
• W2460811036 hasAuthorship W2460811036A5070455368 @default.
• W2460811036 hasAuthorship W2460811036A5074654320 @default.
• W2460811036 hasAuthorship W2460811036A5085712310 @default.
• W2460811036 hasAuthorship W2460811036A5089736242 @default.
• W2460811036 hasBestOaLocation W24608110361 @default.
• W2460811036 hasConcept C121332964 @default.
• W2460811036 hasConcept C126322002 @default.
• W2460811036 hasConcept C1276947 @default.
• W2460811036 hasConcept C141071460 @default.
• W2460811036 hasConcept C143998085 @default.
• W2460811036 hasConcept C150846664 @default.
• W2460811036 hasConcept C197934379 @default.
• W2460811036 hasConcept C2776694085 @default.
• W2460811036 hasConcept C2776755627 @default.
• W2460811036 hasConcept C2778119113 @default.
• W2460811036 hasConcept C2778375690 @default.
• W2460811036 hasConcept C2778476033 @default.
• W2460811036 hasConcept C2778559949 @default.

• next